“The agency’s Investigation and Enforcement department is actively identifying cannabis products tested for microbial contaminants that may not be compliant with Commission regulations.”
We know from the response to past posts about recalls and sudden actions by the Massachusetts Cannabis Control Commission that people flock to and gossip around such news. So we cannot stress enough that, at this juncture, we have no idea what will come from this announcement down the line.
But it’s something to pay close attention to, since the CCC today alerted “Marijuana Establishments and Medical Marijuana Treatment Centers, Certifying Healthcare Providers, Registered Qualifying Patients and Personal Caregivers, and Consumers” about a product that may have been used to test other products, potentially causing problems beyond the initial discovery point.
Here’s the note from CCC Executive Director Shawn Collins:
On March 9, 2023, a Marijuana Establishment notified the Cannabis Control Commission (Commission) of a product recall issued by Medicinal Genomics Corporation (MGC) regarding a test kit that can be used to measure microbial contaminants in cannabis products under proper laboratory conditions.
According to MGC’s Quality Alert Bulletin dated January 18, 2023 (Tab B), this recall was prompted by a potential defect that may have occurred within one specific kit, identified in the alert bulletin by its Stock Keeping Unit no. 420201.
At this time, the Commission has confirmed that only two Independent Testing Laboratories (ITLs) had previously purchased the kit subject to this recall. The agency’s Investigation and Enforcement department is actively identifying cannabis products tested for microbial contaminants that may not be compliant with Commission regulations. The purpose of this bulletin is to inform the public of its active and ongoing investigations into this matter.
The Commission is committed to promoting public health, safety, and welfare. It is possible that some products which passed testing based on the recalled test kits may have moved into the market and remain at Marijuana Establishments or Medical Marijuana Treatment Centers or have been sold. The Commission is investigating this matter and will keep the public updated if it makes findings that implicate an immediate or serious risk to public health, safety, and welfare.
Questions regarding this notice may be directed to the Commission by calling the agency at (774) 415-0200 or emailing Inspections@CCCMass.com.
Developing …
